Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (211-220 of 280) with videos related to

Pageof 28
Sort By:
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Plos One|August 22, 2007
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescenceMarianne A B van der Sande, Pauline A Waight, Maimuna Mendy, et al.
Human Mutation|September 2, 2017
Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer historyKelvin César de Andrade, Lisa Mirabello, Douglas R Stewart, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2010
Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasisMatthieu Lacroix, Julie Caramel, Perrine Goguet-Rubio, et al.
Human Mutation|October 31, 2009
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effectSonia Garritano, Federica Gemignani, Edenir Inez Palmero, et al.
Cancer Letters|February 24, 2006
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian familiesMaria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, et al.
Plos One|January 5, 2012
Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, IranBehnoush Abedi-Ardekani, Farin Kamangar, Masoud Sotoudeh, et al.
Hepatitis Research and Treatment|July 16, 2011
Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandOlivier Galy, Isabelle Chemin, Emilie Le Roux, et al.
American Journal of Human Genetics|November 9, 2010
A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromesAdam Shlien, Berivan Baskin, Maria Isabel W Achatz, et al.
International Journal of Cancer|November 13, 2008
Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomasDenise P Guimarães, Ivanir M Oliveira, Emanuela de Moraes, et al.
Pageof 28

Showing results (211-220 of 280) with videos related to

Sort By:
Pageof 28
JNCI Cancer Spectrum|January 28, 2025
Cancer risk in carriers of TP53 germline variants grouped into different functional categoriesLucas John Müntnich, Christina M Dutzmann, Anika Großhennig, et al.
Plos One|August 22, 2007
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescenceMarianne A B van der Sande, Pauline A Waight, Maimuna Mendy, et al.
Human Mutation|September 2, 2017
Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer historyKelvin César de Andrade, Lisa Mirabello, Douglas R Stewart, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 20, 2010
Transcription factor E4F1 is essential for epidermal stem cell maintenance and skin homeostasisMatthieu Lacroix, Julie Caramel, Perrine Goguet-Rubio, et al.
Human Mutation|October 31, 2009
Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effectSonia Garritano, Federica Gemignani, Edenir Inez Palmero, et al.
Cancer Letters|February 24, 2006
The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian familiesMaria Isabel Waddington Achatz, Magali Olivier, Florence Le Calvez, et al.
Plos One|January 5, 2012
Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, IranBehnoush Abedi-Ardekani, Farin Kamangar, Masoud Sotoudeh, et al.
Hepatitis Research and Treatment|July 16, 2011
Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from ThailandOlivier Galy, Isabelle Chemin, Emilie Le Roux, et al.
American Journal of Human Genetics|November 9, 2010
A common molecular mechanism underlies two phenotypically distinct 17p13.1 microdeletion syndromesAdam Shlien, Berivan Baskin, Maria Isabel W Achatz, et al.
International Journal of Cancer|November 13, 2008
Interferon-inducible guanylate binding protein (GBP)-2: a novel p53-regulated tumor marker in esophageal squamous cell carcinomasDenise P Guimarães, Ivanir M Oliveira, Emanuela de Moraes, et al.
Pageof 28